Table 1.
Generalized | Partial | |||
---|---|---|---|---|
Genetic | Acquired | Genetic | Acquired | |
Subtype | Congenital generalized lipodystrophy | Acquired generalized lipodystrophy | Familial partial lipodystrophy | Acquired partial lipodystrophy |
Genes for autosomal recessive subtypes | AGPAT2, BSCL2, CAV1, CAVIN1 [10–13] | None | CIDEC, LIPE, PCYT1A [14–18] | None |
Genes for autosomal dominant subtypes | None | None | LMNA, PPARG, AKT2, PLIN1, ADRA2A [19–24] | None |
Pathogenesis | Inability to store triglycerides in adipose tissue | Autoimmune, panniculitis, idiopathic (perilipin 1 autoantibody) | Various different mechanisms | Autoimmune (Complement 3 nephritic factor autoantibody) |
Lipodystrophy phenotype | Near total absence of body fat since birth or soon after | Gradual loss of subcutaneous fat from nearly entire body | Absence of fat from the limbs | Absence of fat from the upper body, including the face, neck, arms and chest |
Metabolic complications | + | + | + | Mild or none |
Present